Role of different inflammatory and tumor biomarkers in the development of ulcerative colitis-associated carcinogenesis

Blockade of a Chemokine, CCL2, Reduces Chronic Colitis-Associated Carcinogenesis in Mice

(2009) B. K. Popivanova et al.   CANCER RESEARCH

Enhanced colitis-associated colon carcinogenesis in a novelApcmutant rat

(2009) Kazuto Yoshimi et al.   CANCER SCIENCE

Recent Advances on the Roles of NO in Cancer and Chronic Inflammatory Disorders

(2009) Jagat Kanwar et al.   CURRENT MEDICINAL CHEMISTRY

Inflammation and colorectal cancer

(2009) Sarah Kraus et al.   CURRENT OPINION IN PHARMACOLOGY

Interleukin-6 Trans-Signaling and Colonic Cancer Associated with Inflammatory Bowel Disease

(2009) Stefan Rose-John et al.   CURRENT PHARMACEUTICAL DESIGN

Targeting adrenomedullin receptors with systemic delivery of neutralizing antibodies inhibits tumor angiogenesis and suppresses growth of human tumor xenografts in mice

(2009) Itidal Kaafarani et al.   FASEB JOURNAL

Expression of adrenomedullin in human ovaries, ovarian sex cord–stromal tumors and cultured granulosa–luteal cells

(2009) Jianqi Liu et al.   GYNECOLOGICAL ENDOCRINOLOGY

Expression of tight and adherens junction proteins in ulcerative colitis associated colorectal carcinoma: upregulation of claudin-1, claudin-3, claudin-4, and β-catenin

(2009) S. T. Mees et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Anti-inflammatory neuropeptides: A new class of endogenous immunoregulatory agents

(2008) Mario Delgado et al.   BRAIN BEHAVIOR AND IMMUNITY

Genetic Deletion of mPGES-1 Suppresses Intestinal Tumorigenesis

(2008) M. Nakanishi et al.   CANCER RESEARCH

Wnt and beyond Wnt: Multiple mechanisms control the transcriptional property of β-catenin

(2008) Tianru Jin et al.   CELLULAR SIGNALLING

Aberrant crypt foci: are they intermediate endpoints of colon carcinogenesis in humans?

(2008) Akshay K Gupta et al.   CURRENT OPINION IN GASTROENTEROLOGY

Intestinal Immunomodulation. Role of Regulative Peptides and Promising Pharmacological Activities

(2008) V. Motilva et al.   CURRENT PHARMACEUTICAL DESIGN

Aberrant crypt foci as precursors in colorectal cancer progression

(2008) Frank A. Orlando et al.   JOURNAL OF SURGICAL ONCOLOGY

Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation

(2008) Christopher R Weber et al.   LABORATORY INVESTIGATION

The role of the transcription factor AP-1 in colitis-associated and β-catenin-dependent intestinal tumorigenesis in mice

(2008) P Hasselblatt et al.   ONCOGENE

Acute and chronic responses associated with adrenomedullin administration in experimental colitis

(2008) E. Talero et al.   PEPTIDES

Cancer in inflammatory bowel disease

(2008) Jianlin Xie et al.   WORLD JOURNAL OF GASTROENTEROLOGY